Shared Savings ACOs saved Medicare $1.8B in 2022
Nearly two-thirds of participating accountable care organizations earned payments for their performance last year, according to the CMS.
NextGen reportedly exploring sale
A potential sale for the company comes a month after NextGen agreed to pay $31 million to settle allegations that it violated the False Claims Act.
CVS launches new venture in biosimilar drug experiment
The subsidiary, called Cordavis, will work directly with manufacturers to market or co-produce low-cost biologic drugs, starting with Novartis’ Humira copy.
HHS agency launches project to boost healthcare cybersecurity
The Advanced Research Projects Agency for Health is soliciting proposals for a project that would repurpose national security tech to protect the healthcare industry from cyberattacks.
CMS threatens to cut hospices from Medicare if they can’t prove legitimacy
The crackdown comes after media reports found fraudulent activity in hospice facilities, including those that certified patients for care who were not terminally ill and those that ran “churn and burn” Medicare billing schemes.
‘Project NextGen’ to spend $1.4B in search for better COVID drugs, vaccines
Inspired by Operation Warp Speed, the new federal program aims to fund development and testing of new therapies that can stay ahead of an evolving virus.
Cigna removes prior authorizations for 25% of services
The insurer also plans to nix another 500 codes for its Medicare Advantage plans before the end of this year.
MA beneficiaries like their plans, but few say it’s easy to find care
Though most enrollees were satisfied with their insurance, only 31% said their plans made it easy for them to find care, according to a study by J.D. Power.
Florida sued over Medicaid redeterminations
Three Floridians, including two children, filed a lawsuit against the state on Tuesday alleging it illegally cut their Medicare coverage without proper notice.
Large employers predict pharmacy spend, mental health needs will continue to rise
“The road ahead for prescription drug and pharmacy looks quite daunting,” said the CEO of the Business Group on Health following a recent survey.